Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Elanco Animal Health Inc before investing.
In this article, we go over a few key elements for understanding Elanco Animal Health Inc’s stock price such as:
- Elanco Animal Health Inc’s current stock price and volume
- Why Elanco Animal Health Inc’s stock price changed recently
- Upgrades and downgrades for ELAN from analysts
- ELAN’s stock price momentum as measured by its relative strength
About Elanco Animal Health Inc
(ELAN)
Before we jump into Elanco Animal Health Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Want to learn more about Elanco Animal Health Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Elanco Animal Health Inc.
Elanco Animal Health Inc’s Stock Price as of Market Close
As of September 27, 2024, 3:59 PM, CST, Elanco Animal Health Inc’s stock price was $14.32.
Elanco Animal Health Inc is up 4.3% from its previous closing price of $13.73.
During the last market session, Elanco Animal Health Inc’s stock traded between $13.28 and $13.80. Currently, there are 494.20 million shares of Elanco Animal Health Inc stock available for purchase.
Unfortunately, Elanco Animal Health Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.
Elanco Animal Health Inc Stock Price History
Elanco Animal Health Inc’s
(ELAN) price is currently down 7.43% so far this month.
During the month of September, Elanco Animal Health Inc’s stock price has reached a high of $15.78 and a low of $13.28.
Over the last year, Elanco Animal Health Inc has hit prices as high as $18.80 and as low as $8.52. Year to date, Elanco Animal Health Inc’s stock is up 17.18%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Elanco Animal Health Inc Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 26, 2024, there were 0 analysts who downgraded Elanco Animal Health Inc’s stock and 2 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Elanco Animal Health Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Elanco Animal Health Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Elanco Animal Health Inc’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Elanco Animal Health Inc
(ELAN) by visiting AAII Stock Evaluator.
Relative Price Strength of Elanco Animal Health Inc
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of September 26, 2024, Elanco Animal Health Inc has a weighted four-quarter relative price strength of -2.93%, which translates to a Momentum Score of 52 and is considered to be Average.
Want to learn more about how Elanco Animal Health Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Elanco Animal Health Inc Stock Price: Bottom Line
As of September 27, 2024, Elanco Animal Health Inc’s stock price is $14.32, which is up 4.3% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Elanco Animal Health Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 23.3%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.